{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:52:50Z","timestamp":1791553970465,"version":"4.3.4"},"reference-count":37,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"MSD investigator studies program","award":["100435"],"award-info":[{"award-number":["100435"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,9,14]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/bmjopen-2026-120316","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:30:48Z","timestamp":1791552648000},"page":"e120316","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Pembrolizumab plus lenvatinib in the treatment of unresectable cutaneous angiosarcoma: a study protocol of multicentre, open-label phase II study (NCCH2213, PLAS)"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06673628","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1335-7100","authenticated-orcid":false,"given":"Dai","family":"Ogata","sequence":"first","affiliation":[{"name":"Dermatology, National Cancer Center Japan, Chuo, Tokyo, Japan"},{"name":"Dermatology, University of Miyazaki, Miyazaki, Miyazaki Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nakano","sequence":"additional","affiliation":[{"name":"Dermatology, National Cancer Center Japan, Chuo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"3 Department of Dermatologic Oncology, National Cancer Center Japan, Chuo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Funakoshi","sequence":"additional","affiliation":[{"name":"Keio University, Minato, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Dermatology, National Cancer Center-Hospital East, Kashiwa, Chiba Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Kyoto Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Dermatology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Aichi Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryunosuke","family":"Machida","sequence":"additional","affiliation":[{"name":"National Cancer Center Japan Center for Research Administration and Support Biostatistics Division, Chuo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Nagasaka","sequence":"additional","affiliation":[{"name":"Clinical Research Support Office, National Cancer Center Japan, Chuo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Kagatsume","sequence":"additional","affiliation":[{"name":"Clinical Research Support Office, National Cancer Center Japan, Chuo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Inaba","sequence":"additional","affiliation":[{"name":"Clinical Research Support Office, National Cancer Center Japan, Chuo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Hitomi","sequence":"additional","affiliation":[{"name":"Clinical Research Support Office, National Cancer Center Japan, Chuo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Namikawa","sequence":"additional","affiliation":[{"name":"Department of Dermatologic Oncology, National Cancer Center Japan, Chuo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"2026100906303046000_16.10.e120316.1","unstructured":"Fletcher C . WHO classification of tumours of soft tissue and bone. In: World Health Organization classification of umours. 4th edn. Lyon, France: International Agency for Research on Cancer, 2013: 230."},{"key":"2026100906303046000_16.10.e120316.2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3"},{"key":"2026100906303046000_16.10.e120316.3","unstructured":"Dennis NF , Francis M , Lawrence G . Soft tissue sarcoma incidence and survival: tumours diagnosed in England between 1985 and 2009. United Kingdom: National Cancer Intelligence Network 2012;38\u201342."},{"key":"2026100906303046000_16.10.e120316.4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ejso.2018.02.246","article-title":"Surgery with curative intent is associated with prolonged survival in patients with cutaneous angiosarcoma of the scalp and face -a retrospective study of 38 untreated cases in the Japanese population","volume":"44","author":"Oashi","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"2026100906303046000_16.10.e120316.5","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181dbb75a"},{"key":"2026100906303046000_16.10.e120316.6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870301)59:5<1046::AID-CNCR2820590533>3.0.CO;2-6"},{"key":"2026100906303046000_16.10.e120316.7","doi-asserted-by":"publisher","DOI":"10.1097\/00130404-200505000-00011"},{"key":"2026100906303046000_16.10.e120316.8","unstructured":"Goldblum JR , Folpe AL , Weiss SW , et al . Enzinger and weiss\u2019s soft tissue tumors. 6th edn. Philadelphia: Saunders\/Elsevier, 2014."},{"key":"2026100906303046000_16.10.e120316.9","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z"},{"key":"2026100906303046000_16.10.e120316.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)80097-2"},{"key":"2026100906303046000_16.10.e120316.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2014.05.002"},{"key":"2026100906303046000_16.10.e120316.12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hed.24554","article-title":"Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: Systematic review and meta-analysis","volume":"39","author":"Shin","year":"2017","journal-title":"Head Neck"},{"key":"2026100906303046000_16.10.e120316.13","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/cas.15823","article-title":"Epidemiology of skin cancer based on Japan\u2019s National Cancer Registry 2016-2017","volume":"114","author":"Ogata","year":"2023","journal-title":"Cancer Sci"},{"key":"2026100906303046000_16.10.e120316.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.3146"},{"key":"2026100906303046000_16.10.e120316.15","doi-asserted-by":"crossref","first-page":"109680","DOI":"10.1016\/j.ejso.2025.109680","article-title":"Clinicopathological characteristics, long-term prognosis and follow-up recommendations of primary and secondary cutaneous angiosarcoma: A Danish nationwide population-based cohort study","volume":"51","author":"Abebe","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"2026100906303046000_16.10.e120316.16","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-018-0531-3","article-title":"Current and Future Directions for Angiosarcoma Therapy","volume":"19","author":"Florou","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"2026100906303046000_16.10.e120316.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0749-z"},{"key":"2026100906303046000_16.10.e120316.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30006-8"},{"key":"2026100906303046000_16.10.e120316.19","article-title":"Clinical activity of immune checkpoint blockade in angiosarcoma: a retrospective cohort study","volume":"9","author":"Wagner","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026100906303046000_16.10.e120316.20","first-page":"144","article-title":"TP53 and PIK3CA mutations in angiosarcoma and correlation with ultraviolet mutational signatures","volume":"31","author":"Shon","year":"2018","journal-title":"Mod Pathol"},{"key":"2026100906303046000_16.10.e120316.21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139080"},{"key":"2026100906303046000_16.10.e120316.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2451-6","article-title":"Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Cancer"},{"key":"2026100906303046000_16.10.e120316.23","first-page":"250","article-title":"PD-L1 expression and tumor immune microenvironment in cutaneous angiosarcoma","volume":"88","author":"Honda","year":"2017","journal-title":"J Dermatol Sci"},{"key":"2026100906303046000_16.10.e120316.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70023-1"},{"key":"2026100906303046000_16.10.e120316.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2010.10.007"},{"key":"2026100906303046000_16.10.e120316.26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds237"},{"key":"2026100906303046000_16.10.e120316.27","first-page":"257","article-title":"Sorafenib for patients with advanced angiosarcoma: a phase II trial","volume":"23","author":"Ray-Coquard","year":"2012","journal-title":"Ann Oncol"},{"key":"2026100906303046000_16.10.e120316.28","first-page":"72","article-title":"Pazopanib in advanced vascular sarcomas","volume":"85","author":"Kollar","year":"2017","journal-title":"Eur J Cancer"},{"key":"2026100906303046000_16.10.e120316.29","first-page":"148","article-title":"Clinical activity of pazopanib in angiosarcoma","volume":"21","author":"Ravi","year":"2016","journal-title":"Oncologist"},{"key":"2026100906303046000_16.10.e120316.30","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13806"},{"key":"2026100906303046000_16.10.e120316.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108330"},{"key":"2026100906303046000_16.10.e120316.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035716"},{"key":"2026100906303046000_16.10.e120316.33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00221"},{"key":"2026100906303046000_16.10.e120316.34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00808"},{"key":"2026100906303046000_16.10.e120316.35","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780110703"},{"key":"2026100906303046000_16.10.e120316.36","doi-asserted-by":"crossref","unstructured":"Green S , Benedetti J , Benedetti J . Clinical trials in oncology. 3rd edn. Boca Raton: CRC Press, 2012.","DOI":"10.1201\/b12125"},{"key":"2026100906303046000_16.10.e120316.37","doi-asserted-by":"crossref","first-page":"11503","DOI":"10.1200\/JCO.2023.41.16_suppl.11503","article-title":"A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902)","volume":"41","author":"Grilley-Olson","year":"2023","journal-title":"JCO"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-120316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:30:52Z","timestamp":1791552652000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-120316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,9]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bmjopen-2026-120316"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-120316","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}